| Region | Prevalence of HCV |
| Africa [9, 10] | | Sub-Saharan Africa | 2.2% (0.1%–13.8%) | Central Africa | 6% | West Africa | 2.4% | Southern and East Africa | 1.6% |
| Americas [11–13, 15] | | North America | | Canada | 0.7% | United States | 1.3% | Latin America | | Argentina, Brazil, Mexico, Puerto Rico, Peru, and Venezuela | 1.4–2.5% |
| Asia and Oceania [2, 16, 22–27] | | South Asia | | India | 3.4% | Southeast Asia | | Vietnam | 2–2.9% | East Asia | | Taiwan | 4.4% | China | 1–1.9% | Australasia (Australia and New Zealand) | 2.7% | Melanesia,Micronesia,and Polynesia regions | 2.6% |
| Eastern Mediterranean [10, 16, 17] | | Egypt | 15% | Pakistan | 4.9% |
| Europe [21] | | Central Europe | | Czech Republic, Poland, Romania, and Hungary | ≤0.5% | Romania | ≥3% | Western Europe | | France, Germany, Greece, Italy, Norway, Portugal, Spain, Sweden, Switzerland, and UK | ≤0.5% | Rural areas in Greece and in Italy | ≥3% | Eastern Europe | | Russia | ≤0.5% | Parts of Russia | ≥3% |
|
|